Stockreport

Emergent BioSolutions Inc (EBS) Reports Mixed Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]

Emergent Biosolutions, Inc.  (EBS) 
Last emergent biosolutions, inc. earnings: 4/30 04:08 pm Check Earnings Report
US:NYSE Investor Relations: investors.emergentbiosolutions.com
PDF Adjusted EBITDA: Q4 2023 Adjusted EBITDA was $3.4 million, a significant drop from $44.0 million in Q4 2022. Product Sales: NARCAN sales increased by 22% in Q4 2023, [Read more]